ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
28 hedge funds and large institutions have $621K invested in Anthera Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
-9
Holders Change %
-24.32%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
6
Closed
16
Calls
$452K
Puts
$14K
Net Calls
+$438K
Net Calls Change
-$436K
Top Buyers
1 |
Renaissance Technologies
New York
|
+$132K |
2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$129K |
3 |
VF
Virtu Financial
New York
|
+$46.6K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.9K |
5 |
Goldman Sachs
New York
|
+$37K |
Top Sellers
1 |
BI
BVF Inc
San Francisco,
California
|
-$2.01M |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.3M |
3 |
AC
Armistice Capital
New York
|
-$1.27M |
4 |
6CM
683 Capital Management
New York
|
-$399K |
5 |
Millennium Management
New York
|
-$111K |